COPD is the fourth most common cause of death. Gender Bias in the Diagnosis of COPD*

Size: px
Start display at page:

Download "COPD is the fourth most common cause of death. Gender Bias in the Diagnosis of COPD*"

Transcription

1 Gender Bias in the Diagnosis of COPD* Kenneth R. Chapman, MD, FCCP; Donald P. Tashkin, MD, FCCP; and David J. Pye, PhD Background: COPD is thought to be more prevalent among men than women, a finding usually attributed to higher smoking rates and more frequent occupational exposures of significance for men. However, smoking prevalence has increased among women and there is evidence that women may be more susceptible to the adverse pulmonary function effects of smoking than men. There may also be underdiagnosis and misdiagnosis of COPD in both sexes because objective measures of lung function are underused. Objectives: We undertook the present study to determine if there is gender bias in the diagnosis of COPD, such that women are less likely than men to receive a diagnosis of COPD. We also attempted to determine if underuse of lung function measurements was a factor in any bias detected. Methods: We surveyed a random sample of 192 primary-care physicians (96 American and 96 Canadian; 154 men and 38 women) using a hypothetical case presentation and a structured interview. The case of cough and dyspnea in a smoker was presented in six versions differing only in the age and sex of the patient. After presentation of the history and physical findings, physicians were asked to state the most probable diagnosis and to choose the diagnostic studies needed. Physicians were then presented with spirometric findings of moderate or severe obstruction without significant bronchodilator response, and the questions repeated. Finally, the negative outcome of an oral steroid trial was described. Results: Initially, COPD was given as the most probable diagnosis significantly more often for men than women (58% vs 42%; p < 0.05). The likelihood of a COPD diagnosis increased significantly and initial differences between sexes decreased as objective information was provided. After spirometry, COPD diagnosis rates for men and women were 74% vs 66% (p not significant); after the steroid trial 85% vs 79% (p not significant). Only 22% of physicians would have requested spirometry after the initial presentation. Conclusions: In North America, primary-care physicians underdiagnose COPD, particularly in women. Spirometry reduces the risk of underdiagnosis and gender bias but is underused. (CHEST 2001; 119: ) Key words: asthma; misdiagnosis; physician decision making; spirometry; underdiagnosis COPD is the fourth most common cause of death in North America and remains the only common cause of mortality that is increasing in prevalence. Despite an overall decline in the prevalence of cigarette smoking since the pivotal report of the Surgeon General in the mid-1960s, we continue to *From the Division of Respiratory Medicine (Dr. Chapman), Department of Medicine, University of Toronto, Toronto, Ontario, Canada; UCLA School of Medicine (Dr. Tashkin), Los Angeles, CA; and Westmount Research Consultants (Dr. Pye), Toronto, Ontario, Canada. The authors received a research grant-in-aid from Boehringer Ingelheim Canada Ltd and Boehringer Ingelheim Pharmaceuticals Inc. Manuscript received April 12, 2000; revision accepted January 3, Correspondence to: Kenneth R. Chapman, MD, FCCP, Asthma Center of the University Health Network, Suite ECW, 399 Bathurst St, Toronto, Ontario M5T 2S8, Canada; kchapman@inforamp.net witness the late pulmonary sequelae of tobacco consumption. Diagnosed COPD appears to be more prevalent in men than women, whether expressed in terms of mortality or hospital separation data. This is usually attributed to the historically higher rates of cigarette smoking among men and their greater likelihood of exposure to significant occupational respiratory irritants. However, these risk factors have shifted dramatically in the past several decades. Cigarette smoking is now as common or more common among women as compared to men, and more women than before now work outside the home in occupations once held almost exclusively by men. There is also growing evidence that women may be more susceptible to the adverse pulmonary consequences of tobacco smoking. In the Lung Health Study 1 of mild COPD, the prevalence of a positive methacholine challenge finding was 25% among men CHEST / 119 / 6/ JUNE,

2 but 48% among women. In two Danish population studies 2 of 13,897 subjects followed for between 7 and 16 years, women who smoked had a higher rate of lung function decline per amount smoked than men and were at greater risk of being hospitalized for the treatment of COPD. Although women are clearly at increasing risk of developing COPD, the diagnosis continues to be made much more commonly in men. By contrast, in studies 3 of emergency department and ambulatory clinic care of asthma, women present with doctordiagnosed asthma more often than men. Such findings could be explained by a gender bias among physicians in their diagnosis of different types of respiratory diseases. This has been well documented for other tobacco-related illnesses such as coronary artery disease. It is plausible that misdiagnosis, including possible gender bias, could be reduced by the appropriate use of objective laboratory studies. Unfortunately, previous studies 4 have shown that physicians make little use of spirometry in their investigation of chronic respiratory symptoms. We therefore undertook the following study to determine if North American physicians reached similar provisional diagnoses for hypothetical male and female patients presenting with identical chronic respiratory symptoms and identical smoking histories. We also sought to examine test-ordering behavior by physicians presented with these clinical scenarios, as well as the impact on their diagnoses when objective pulmonary function data were provided to them. Study Design Materials and Methods We devised one hypothetical case summary to present to primary-care physicians for their review and management. The summary described a middle-aged former smoker (of approximately 40 pack-years consumption) who presented with morning cough persisting for 4 years and worsening intermittently following viral respiratory tract infections. For 3 years, the patient had been troubled by breathlessness on moderate exertion. On physical examination, the only abnormal finding was the presence of expiratory wheezes throughout the chest. In randomized fashion, half the physicians were told that the patient was a woman, and half were told that the patient was a man. Also in random fashion, the age of the patient was given as 47 years or 59 years in balanced fashion between the sexes. Using a structured questionnaire, trained interviewers who were blinded to the major objectives of the study asked physicians to state the most likely diagnosis and the diagnostic studies needed. Independent of the provisional diagnosis offered or the tests requested, all physicians were provided with a set of laboratory test results for the hypothetical patient. These comprised normal routine blood analyses (hemoglobin, WBC count, sedimentation rate, electrolytes, liver enzymes, BUN, and creatinine), a normal ECG finding, and a normal chest radiograph finding. In addition, an abnormal spirometric result was reported. In balanced randomized fashion, physicians were shown one of two sets of numerical spirometric data (FVC, FEV 1, and FEV 1 /FVC) accompanied by interpretations characterizing the results as a moderate or severe obstructive defect. These corresponded with values of FEV 1 of 52% or 32% of predicted, respectively, and with values of FEV 1 /FVC of 43% and 27%, respectively. Half the respondents also received postbronchodilator numerical results characterized as showing minimal change. Once again, physicians were asked to offer their most probable diagnosis. After this was given, physicians were provided with negative oral steroid trial results for the hypothetical patient. That is, the patient was described as using prednisone, 40 mg/d, for 2 weeks with no significant change in FEV 1. After this information had been given, physicians were asked for the last time to provide a diagnosis. The diagnostic and test ordering terminology used by physicians was categorized by an a priori scheme. Terms not accounted for by the a priori scheme were categorized by two of the investigators blinded to the gender, age, and degree of obstruction that had elicited the response. Physicians Surveyed Before the survey instrument was used for the main physician sample, we tested its plausibility, clarity, and consistency on a convenience sample of 21 primary-care and respiratory specialist physicians from two Canadian cities and two US cities. With minor changes in terminology, the instrument was then administered to a sample of 96 US primary-care physicians and 96 Canadian primary-care physicians selected in random fashion from two commercial databases of practicing physicians. In each country, physician sampling was from seven geographic regions ranging from coast to coast. Data Analysis An analysis of variance model was used to assess the influence of patient gender and patient age on the frequency of COPD diagnoses offered by physicians following presentation of the history and physical examination results. A repeated-measures analysis of variance model was used to assess the influence of these and additional factors on the frequency of COPD diagnoses over the three stages of the interview as additional data were offered. These additional factors were severity of obstruction, availability of bronchodilator test results, and nationality of the responding physician. Proportions of tests ordered by US and Canadian physicians were compared by 2 test. Results were considered significant at the p 0.05 level. Results Physicians Surveyed We surveyed a random sample of 192 primarycare physicians (96 American and 96 Canadian; 154 men and 38 women). In the United States, interviews were conducted in the following geographic areas (major urban center and surrounding nonurban region): Chicago, San Francisco, Seattle, Houston, Denver, Long Island, and Atlanta. In Canada, interviews were conducted in the following geographic areas (major urban center and surrounding 1692 Clinical Investigations

3 nonurban region): Toronto, Montreal, Vancouver, Calgary, Winnipeg, London, and Quebec City. For each physician who participated in the survey, three who were contacted did not. The most common reason given for nonparticipation was inability to schedule an appointment with the interviewer during the few days available for survey participation in each city. Rates of participation were similar between Canada and the United States. Diagnoses Only 57% of physicians offered COPD as the most likely diagnosis following presentation of the history and physical examination. As shown in Table 1, COPD was significantly more likely to be offered as the provisional diagnosis for the hypothetical male patient than the hypothetical female patient (64.6% vs 49.0%; p 0.05). Patient age was not significantly related to the diagnosis offered. The likelihood of a provisional COPD diagnosis increased significantly (to 70%) after presentation of abnormal spirometric findings (p 0.001) and the disparity between male and female patients decreased. There was a further increase in the number of COPD diagnoses offered by physicians after presentation of the negative oral steroid trial results (p 0.001). The disparity in diagnosis between hypothetical male and female patients decreased further. The most common alternative diagnosis was asthma, a provisional diagnosis offered 35% of the time after the initial presentation, 27% of the time after abnormal spirometric results were offered, and 14% of the time after a negative oral steroid trial was described. Although the availability of spirometric data caused a significant increase in the frequency of COPD diagnoses for both sexes, we could detect no effect on diagnoses offered by the severity of obstruction or the availability of negative bronchodilator response data. At all three stages of management of the hypothetical patient, asthma was a significantly more common alternative diagnosis for the female patient than the male patient (Table 1). Approximately 8% of physicians offered alternative nonrespiratory diagnoses, primarily cardiovascular disease, and the frequency of such diagnoses was unchanged by the presentation of spirometric and oral steroid trial data. We could detect no significant effect of physician nationality or gender on diagnosis. Diagnostic Studies Requested After the initial presentation of the hypothetical patient, the most commonly requested study was a chest radiograph; this was requested by approximately 80% of both American and Canadian physicians (Table 2). Other diagnostic studies were requested far less frequently as listed in Table 2. In particular, only 21.8% of physicians requested spirometry, a test requested slightly more frequently by American physicians than Canadian physicians (p 0.05). American physicians also ordered blood analyses, ECGs, and arterial blood gas measurements more frequently than their Canadian counterparts. A small number of requests for methacholine challenge tests came only from Canadian practitioners. There were no significant differences between men and women physicians in their test-ordering behavior. Discussion Our data show that many primary-care physicians in North America are reluctant to consider the diagnosis of COPD, even when confronted by a middle-aged former smoker with chronic cough, dyspnea, and wheezes on physical examination. Moreover, they are less likely to make the diagnosis of COPD in women than in men, a diagnostic bias that is eliminated by the presentation of compatible spirometric data. Regrettably, only a minority of primary-care physicians would consider requesting spirometry in their investigation of the dyspneic patient with wheezes and a substantial smoking history. Ours is not the first study to document a physician bias toward diagnosing tobacco-related diseases more readily in men as compared to women. Women who suffer chest pain are less likely than men to be referred for invasive testing such as angiography, implying a bias against the diagnosis of coronary Table 1 Percentage of Diagnoses Offered at Each Stage of the Survey Process History and Physical Spirometry Oral Steroid Trial Diagnosis Male Female Male Female Male Female COPD Asthma Other, nonrespiratory CHEST / 119 / 6/ JUNE,

4 Table 2 Diagnostic Studies Requested After the Initial Presentation of the Patient* Location Chest Radiograph Blood Analysis ECG Spirometry Sputum Culture ABG Analysis Methacholine Challenge United States Canada Total *Data are presented as percentage of physicians requesting study. ABG arterial blood gas. p artery disease in women or a bias toward the diagnosis in men. 5 Various explanations have been offered for the differences in diagnostic rates between men and women in certain disease settings. For example, it has been suggested that men and women may perceive or report some symptoms differently. 6 It is also been noted that men and women use the health-care system differently. 7 Women use primarycare services more frequently than men and receive more health-care services even when reproductiverelated care is excluded. 8 Curiously, women are less likely to receive specialist referrals than men. 8 However, our study does not support these hypotheses, given that gender bias was present in the absence of specific patient behavior or perceptions. The details presented in our hypothetical scenario were identical for male and female patients. Thus, our findings reflect a preexisting physician bias that is not related to differences in patient personality, communication skills, or expressed preferences. Some might argue that such a bias in a tobaccorelated disease is appropriate. That is, they would argue that the risk of COPD is truly higher in men then in women given the historically higher tobacco consumption rates in men. However, we believe that this argument is flawed in several ways. First, the argument is a tautology. That is, epidemiologic data comparing the prevalence of various diseases by sex and age are dependent on accurate physician diagnosis. There is no single and clearly defined laboratory test for COPD or asthma, and currently published diagnostic criteria are confusing and vague with overlapping features between the syndromes. 9,10 Thus, to argue that men have COPD more commonly than women is indeed circular given the findings of the present study. Second, a slightly higher prevalence of a given disease is irrelevant in the diagnostic approach to individual patients. Even if COPD were somewhat more common in men than women, a physician would be unwise to dismiss the possibility of COPD in any woman suffering from exertional breathlessness and wheezing against a background of tobacco consumption. Our study confirms our earlier report that spirometry is underused by primary-care physicians in North America. 4 We have previously surveyed primary-care physicians in Canada, presenting them with a hypothetical scenario similar to the one used in the present study. We discovered that only 5% of Canadian physicians would request spirometry when presented with a middle-aged smoker who suffered from recurrent productive cough over 2 consecutive years and presented with expiratory wheezes on physical examination. In our earlier study, physicians increased their requests for spirometry if they were presented with the diagnostic term chronic bronchitis as part of the medical history. However, even with this prompting, the rate of requesting spirometry was 40%. We note that spirometry and objective measures of lung function are also poorly utilized in the assessment of asthma. We have previously described the clinical characteristics of patients referred for methacholine challenge testing and found to have negative studies. 11 The majority of patients had received a diagnosis of asthma by their primary-care physicians and had endured treatment with an average of two or more antiasthma medications for 2 years. Thus, the provisional diagnosis of airways disease is anything but temporary. It may sometimes lead to prolonged periods of inappropriate therapy. Our study also reveals that there is considerable diagnostic confusion between COPD and asthma, the most common alternative diagnosis offered by physicians. We find it significant that the initial ratio of men (58%) to women (42%) accorded the diagnosis of COPD is almost the mirror image of the gender ratio for asthma in a variety of studies of emergency or ambulatory care. 3,12 Some might argue that the phenomenon of diagnostic exchange between the sexes is trivial and might note that in our study the diagnosis of an obstructive lung disease (regardless of subtype) was similar between the sexes. However, this diagnostic imprecision ignores the marked and diverging differences in prognosis and therapy between asthma and COPD. Of particular concern to postmenopausal women incorrectly labeled as having asthma would be the increased likelihood of corticosteroid treatment. Several studies 13,14 now report an increased likelihood of de Clinical Investigations

5 creased bone density as a dose-related consequence of inhaled corticosteroid exposure. It is disturbing to note that some physicians in our survey were remarkably reluctant to use the diagnostic term COPD or equivalent. Even after the description of persistent and unchanging obstruction following 2 weeks of oral steroid therapy, one in seven physicians would continue to use the diagnostic label asthma. This could help to explain our reported findings from other surveys of respiratory disease management. We have found that physicians often prescribe similarly for asthma and COPD patients despite distinguishing in a theoretical sense between the illnesses. 4,15 It is also possible that some physicians have chosen not to use the diagnostic terms COPD or emphysema, as the former has little meaning for patients and the latter may be alarming to patients. They may prefer the term asthma themselves, regarding it as a disease more amenable to therapy and more rewarding to treat than COPD. We have no explanation for the responses of 4% of the physicians who continued to offer nonrespiratory diagnoses as the most likely explanation for dyspnea after presentation spirometric data showed moderate or severe airflow limitation unresponsive to treatment with bronchodilators or steroids. Some limitations to our study must be noted. First, we did not test the actual practice behavior of physicians we surveyed, behavior that might differ somewhat from the responses recorded following the presentation of written materials. Nevertheless, our findings are consistent with published epidemiologic and clinical trial data and we believe they are a reasonable reflection of actual practice. Second, we did not attempt to determine the reasons for the provisional diagnoses offered; therefore, we have no explanation for the underdiagnosis, gender bias, and lack of pulmonary function testing seen. Further research is needed to determine the factors responsible for the behaviors observed if appropriate corrective steps such as physician education are to be taken. Third, we cannot identify which types of physician practice or training backgrounds are associated with a neglect of objective spirometric testing or with gender bias in the diagnosis of obstructive lung disease. We sought by our screening process to identify self-described family doctors in active practice and read a descriptive statement to each potential participant. It is possible that a small number of primary-care internists participated in the study in the United States but too few to allow meaningful comparison to the remaining primarycare physicians. References 1 Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD: the Lung Health Study. Am J Respir Crit Care Med 1994; 150: Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal study. Eur Respir J 1997; 10: Rea HH, Garrett JE, Mulder J, et al. Emergency room care of asthmatics: a comparison between Auckland and Toronto. Ann Allergy 1991; 66: Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest 1993; 104: Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991; 325: Kühni CE, Sennhauser FH. The Yentl syndrome in childhood asthma: risk factors for undertreatment in Swiss children. Pediatr Pulmonol 1995; 19: Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care 1988; 26: Franks P, Clancy CM, Naumburg EH. Sex, access and excess. Ann Intern Med 1995; 123: Celli BR, Snider GL, Heffner J, et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77 S Sheffer AL, Bousquet J, Busse WW, et al. International consensus report on diagnosis and management of asthma. Bethesda, MD: US Department of Health and Human Services, 1992; publication No Joyce DP, Chapman KR, Kesten S. Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest 1996; 109: Jackevicius C, Joyce DP, Kesten S, et al. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest 1997; 111: Hanania NA, Chapman KR, Sturtridge WC, et al. Doserelated decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995; 96: Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994; 105: Jackevicius CA, Chapman KR. Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey. Ann Pharmacother 1997; 31: CHEST / 119 / 6/ JUNE,

COPD and Asthma Differential Diagnosis

COPD and Asthma Differential Diagnosis COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive

More information

FIBROGENIC DUST EXPOSURE

FIBROGENIC DUST EXPOSURE FIBROGENIC DUST EXPOSURE (ASBESTOS & SILICA) WORKER S MEDICAL SCREENING GUIDELINE Prepared By Dr. T. D. Redekop Chief Occupational Medical Officer Workplace Safety & Health Division Manitoba Labour & Immigration

More information

Interpretation of Pulmonary Function Tests

Interpretation of Pulmonary Function Tests Interpretation of Pulmonary Function Tests Dr. Sally Osborne Cellular & Physiological Sciences University of British Columbia Room 3602, D.H Copp building 604 822-3421 sally.osborne@ubc.ca www.sallyosborne.com

More information

ASTHMA IN INFANTS AND YOUNG CHILDREN

ASTHMA IN INFANTS AND YOUNG CHILDREN ASTHMA IN INFANTS AND YOUNG CHILDREN What is Asthma? Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma are variable. That means that they can be mild to severe, intermittent to

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) DuPage Medical Group Case Study Organization Profile Established in 1999, DuPage Medical Group (DMG) is a multispecialty

More information

MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES

MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES RECOMMENDATIONS MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES Evaluation for possible asthma 1. Active duty service members should be diagnosed with asthma or exerciseinduced bronchospasm on the basis of the

More information

Your Go-to COPD Guide

Your Go-to COPD Guide Your Go-to COPD Guide Learning how to live with chronic obstructive pulmonary disease (COPD) Inside, you ll learn: COPD facts COPD symptoms and triggers How to talk with your doctor Different treatment

More information

Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease

Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease By John W. Walsh, Co-Founder and President of the COPD Foundation Breathing Easier In

More information

PLAN OF ACTION FOR. Physician Name Signature License Date

PLAN OF ACTION FOR. Physician Name Signature License Date PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes

More information

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,

More information

OSHA INITIAL ASBESTOS MEDICAL QUESTIONNAIRE

OSHA INITIAL ASBESTOS MEDICAL QUESTIONNAIRE OSHA INITIAL ASBESTOS MEDICAL QUESTIONNAIRE 1. NAME 2. SOCIAL SECURITY NUMBER # 3. CLOCK NUMBER FULL TIME PART TIME 4. PRESENT OCCUPATION 5. PLANT / Department 6. ADDRESS (City, ST Zip) 8. TELEPHONE NUMBER

More information

PTE Pediatric Asthma Metrics Reporting Updated January 2015

PTE Pediatric Asthma Metrics Reporting Updated January 2015 PTE Pediatric Asthma Metrics Reporting Updated January 20 Introduction: The Maine Health Management Coalition s (MHMC) Pathways to Excellence (PTE) Program is preparing for its next round of PTE Pediatric

More information

1. NAME 2. SOCIAL SECURITY NUMBER # 4. PRESENT OCCUPATION 5. PLANT 6. ADDRESS 8. TELEPHONE NUMBER 9. INTERVIEWER

1. NAME 2. SOCIAL SECURITY NUMBER # 4. PRESENT OCCUPATION 5. PLANT 6. ADDRESS 8. TELEPHONE NUMBER 9. INTERVIEWER ASBESTOS INITIAL MEDICAL QUESTIONNAIRE 1. NAME 2. SOCIAL SECURITY NUMBER # 3. CLOCK NUMBER 4. PRESENT OCCUPATION 5. PLANT 6. ADDRESS 7. (Zip Code) 8. TELEPHONE NUMBER 9. INTERVIEWER 10. DATE 11. Date of

More information

The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.

The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization. Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should

More information

Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication

Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication 2009 Insights for Improvement: Advancing COPD Care Through Quality Measurement An NCQA Insights for Improvement Publication Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema,

More information

GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1. Pre-release Article for Examination in January 2010 JD*(A09-1661-01A)

GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1. Pre-release Article for Examination in January 2010 JD*(A09-1661-01A) GCE AS/A level 1661/01A APPLIED SCIENCE UNIT 1 Pre-release Article for Examination in January 2010 JD*(A09-1661-01A) 2 BLANK PAGE 3 Information for Teachers The attached article on asthma is based on some

More information

Hardie, Grace (PI) (2000-2001 and 2001-2002) Post Doctoral Nurse Fellowship: $43,200.00 awarded by the Veterans Administration Washington, DC.

Hardie, Grace (PI) (2000-2001 and 2001-2002) Post Doctoral Nurse Fellowship: $43,200.00 awarded by the Veterans Administration Washington, DC. Grace E. Hardie, PhD, RN Associate Professor, School of Nursing Burk Hall 387 San Francisco State University Grants: Hardie, Grace (PI) (2002-2007) RIMI, National Center for Health Minority Disease: $534,954.00

More information

Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Development of disability in COPD The decline in airway function may initially go unnoticed as people adapt their lives to avoid

More information

Department of Surgery

Department of Surgery What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.

More information

Population Health Management Program

Population Health Management Program Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care

More information

RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP

RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families

More information

COPD PROTOCOL CELLO. Leiden

COPD PROTOCOL CELLO. Leiden COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on

More information

Chronic obstructive pulmonary disease (COPD)

Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Breathe With Ease. Asthma Disease Management Program

Breathe With Ease. Asthma Disease Management Program Breathe With Ease Asthma Disease Management Program MOLINA Breathe With Ease Pediatric and Adult Asthma Disease Management Program Background According to the National Asthma Education and Prevention Program

More information

written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd

written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are two major diseases included in

More information

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs

More information

1 ALPHA-1. Am I an Alpha-1 Carrier? FOUNDATION FOUNDATION. Learn how being an Alpha-1 carrier can affect you and your family

1 ALPHA-1. Am I an Alpha-1 Carrier? FOUNDATION FOUNDATION. Learn how being an Alpha-1 carrier can affect you and your family Am I an Alpha-1 Carrier? 1 ALPHA-1 FOUNDATION The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide.

More information

SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD)

SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD) SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD) CONTENTS I. INTRODUCTION II. BACKGROUND INFORMATION A. What Is Spirometry? B. Why Perform Spirometry?

More information

Understanding COPD. Carolinas Healthcare System

Understanding COPD. Carolinas Healthcare System Understanding COPD Carolinas Healthcare System 2013 This self-directed learning module contains information about the pathophysiology, diagnosis, and treatment of COPD. Target Audience: All RNs and LPNs

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

Preoperative Laboratory and Diagnostic Studies

Preoperative Laboratory and Diagnostic Studies Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Geisinger Health System Case Study Profile Geisinger Health System is a physician-led, fully integrated healthcare

More information

An Overview of Asthma - Diagnosis and Treatment

An Overview of Asthma - Diagnosis and Treatment An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,

More information

United Lung & Sleep Clinic Asbestos Questionnaire

United Lung & Sleep Clinic Asbestos Questionnaire Date United Lung & Sleep Clinic Asbestos Questionnaire 1. Name,, Last First M.I. 2. Address 3. Home Phone: ( ) - Area Code,, City State Zip Code 4. Social Security # : - - 5. Birthdate: / / Month Day Year

More information

PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops

PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops YOU SHOULD READ THE FOLLOWING MATERIAL BEFORE Tuesday March 30 Interpretation of PFTs Learning Objectives 1. Specify the indications

More information

Pathway for Diagnosing COPD

Pathway for Diagnosing COPD Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational

More information

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,

More information

Tests. Pulmonary Functions

Tests. Pulmonary Functions Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic

More information

Louisiana Report 2013

Louisiana Report 2013 Louisiana Report 2013 Prepared by Louisiana State University s Public Policy Research Lab For the Department of Health and Hospitals State of Louisiana December 2015 Introduction The Behavioral Risk Factor

More information

National Learning Objectives for COPD Educators

National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the

More information

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children 7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists

More information

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Geisinger Health System Case Study Organization Profile Geisinger Health System is a physician-led, fully integrated

More information

Emphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide.

Emphysema. Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide. Emphysema Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects about 64 million people worldwide. Emphysema involves damage to the air sacs in the lungs. This

More information

Sponsor Novartis Pharmaceuticals

Sponsor Novartis Pharmaceuticals Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study

More information

BREATHE EASY. Despite an improved understanding of. How to Approach Unresponsive Asthma

BREATHE EASY. Despite an improved understanding of. How to Approach Unresponsive Asthma BREATHE EASY How to Approach Unresponsive Asthma When challenged by asthma that won t adequately respond to treatment, what can a physician do? There are a few simple questions one can ask that should

More information

Asthma and COPD Diagnoses and prescriptions in Swedish primary care

Asthma and COPD Diagnoses and prescriptions in Swedish primary care Asthma and COPD Diagnoses and prescriptions in Swedish primary care Paolina Weidinger Department of Primary Health Care Institute of Medicine Sahlgrenska Academy at University of Gothenburg Gothenburg

More information

Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation

Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation Clinical Review Article Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation David M. Mannino, MD, FCCP Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction

More information

Respiratory Care. A Life and Breath Career for You!

Respiratory Care. A Life and Breath Career for You! Respiratory Care A Life and Breath Career for You! Respiratory Care Makes a Difference At 9:32 am, Lori Moreno brought a newborn baby struggling to breathe back to life What have you accomplished today?

More information

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Lung disease in Australia Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Prepared for Lung Foundation Australia

More information

Pharmacology of the Respiratory Tract: COPD and Steroids

Pharmacology of the Respiratory Tract: COPD and Steroids Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart

More information

Smoking Cessation Program

Smoking Cessation Program Smoking Cessation Program UHN Information for people who are ready to quit smoking Read this information to learn: why you should quit smoking how the Smoking Cessation Program works treatments to help

More information

Testimony of. Dr. James Crapo. April 26, 2005

Testimony of. Dr. James Crapo. April 26, 2005 Testimony of Dr. James Crapo April 26, 2005 Written Statement of Dr. James D. Crapo, Professor of Medicine, National Jewish Medical and Research Center and University of Colorado Health Sciences Center

More information

PCOM Letterhead [Substitute same from participating institution and, of course, change Department, PI, and Co-Investigators]

PCOM Letterhead [Substitute same from participating institution and, of course, change Department, PI, and Co-Investigators] PCOM Letterhead [Substitute same from participating institution and, of course, change Department, PI, and Co-Investigators] Department of Neuroscience, Physiology and Pharmacology 215-871-6880 PATIENT

More information

Cough, as a leading symptom, would certainly be in the top 10 of reasons for seeing a GP.

Cough, as a leading symptom, would certainly be in the top 10 of reasons for seeing a GP. COUGH Cough, as a leading symptom, would certainly be in the top 10 of reasons for seeing a GP. A cough in a child seems to cause more concern, even when it has not been present very long, whereas in adults

More information

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD Public Outcomes Report Lung Cancer Submitted by Omar A. Majid, MD Lung cancer is the most common cancer-related cause of death among men and women. It has been estimated that there will be 226,1 new cases

More information

Case-Control Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Case-Control Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION

1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION What is Alpha-1? A family history... of lung disease? of liver disease? What you need to know about Alpha-1 Antitrypsin Deficiency 1 ALPHA-1 FOUNDATION What is Alpha-1? Alpha-1 Antitrypsin Deficiency (Alpha-1)

More information

COPD It Can Take Your Breath Away www.patientedu.org

COPD It Can Take Your Breath Away www.patientedu.org written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are 2 major diseases included in COPD:

More information

Logistics. Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.

Logistics. Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train. . DSHS Grand Rounds Logistics Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at: https://tx.train.org Streamlined registration for individuals not requesting

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am

Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation

More information

Achieving Quality and Value in Chronic Care Management

Achieving Quality and Value in Chronic Care Management The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of

More information

Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS)

Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS) Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS) Based on the Global Strategy for Asthma Management and Prevention and the Global Strategy for

More information

Coding Guidelines for Certain Respiratory Care Services July 2014

Coding Guidelines for Certain Respiratory Care Services July 2014 Coding Guidelines for Certain Respiratory Care Services Overview From time to time the AARC receives inquiries about respiratory-related coding and coverage issues through its Help Line or Coding Listserv.

More information

Pulmonary Rehabilitation. Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Center Seattle, Washington 10/13/07

Pulmonary Rehabilitation. Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Center Seattle, Washington 10/13/07 Pulmonary Rehabilitation Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Seattle, Washington 10/13/07 Pulmonary Rehabilitation Created in the 1970 s Initially intended for COPD

More information

Background information

Background information Background information Asthma Asthma is a complex disease affecting the lungs that can be managed but cannot be cured. 1 Asthma can be controlled well in most people most of the time, although some people

More information

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15 Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15 April 2015 Dr Kieron Earney & Kate Symons Acknowledgements Dr Sarah Deedat Public Health Lead for Long Term Conditions 1 1.

More information

Exercise-Induced Bronchospasm* Coding and Billing for Physician Services

Exercise-Induced Bronchospasm* Coding and Billing for Physician Services CHEST Topics in Practice Management Exercise-Induced Bronchospasm* Coding and Billing for Physician Services Carol Pohlig, BSN, RN Physician reporting of the service to insurance companies for reimbursement

More information

Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology

Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education Chris Orelup, MS3 Max Project 3/1/01 Pediatric Asthma The leading cause of illness in childhood 10, 000, 000 school absences

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

Prevention of Acute COPD exacerbations

Prevention of Acute COPD exacerbations December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal

More information

Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers

Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Stephen M. Levin, M.D. Mount Sinai School of Medicine New York, New York November 1994 The Center to Protect Workers

More information

Pulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Pulmonary Disorders Chronic Obstructive Pulmonary Disease (COPD) Characterized by decreased expiratory airflow Reduction in expiratory

More information

Wireless Remote Monitoring System for ASTHMA Attack Detection and Classification

Wireless Remote Monitoring System for ASTHMA Attack Detection and Classification Department of Telecommunication Engineering Hijjawi Faculty for Engineering Technology Yarmouk University Wireless Remote Monitoring System for ASTHMA Attack Detection and Classification Prepared by Orobh

More information

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

More information

An Outcomes Strategy for COPD and Asthma: NHS Companion Document

An Outcomes Strategy for COPD and Asthma: NHS Companion Document An Outcomes Strategy for COPD and Asthma: NHS Companion Document 1 DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance

More information

Article details. Abstract. Version 1

Article details. Abstract. Version 1 Article details Title Authors Abstract Version 1 Osteoarthritis in Family Physician Practices in Canada: A Report of the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) Morkem, Rachael; Birtwhistle,

More information

Public Health Strategic Framework for COPD Prevention

Public Health Strategic Framework for COPD Prevention Public Health Strategic Framework for COPD Prevention National Center for Chronic Disease Prevention and Health Promotion Division of Adult and Community Health Suggested Citation: Centers for Disease

More information

Better Breathing with COPD

Better Breathing with COPD Better Breathing with COPD People with Chronic Obstructive Pulmonary Disease (COPD) often benefit from learning different breathing techniques. Pursed Lip Breathing Pursed Lip Breathing (PLB) can be very

More information

F r e q u e n t l y As k e d Qu e s t i o n s. Lung Disease

F r e q u e n t l y As k e d Qu e s t i o n s. Lung Disease Lung Disease page 1 Q: What is lung disease? A: Lung disease refers to disorders that affect the lungs, the organs that allow us to breathe. Breathing problems caused by lung disease may prevent the body

More information

understanding the professional guidelines

understanding the professional guidelines SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

Pneumonia Education and Discharge Instructions

Pneumonia Education and Discharge Instructions Pneumonia Education and Discharge Instructions Pneumonia Education and Discharge Instructions Definition: Pneumonia is an infection of the lungs. Many different organisms can cause it, including bacteria,

More information

Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides

Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides W. Susan Cheng, PhD, MPH Rebecca Carlstrom, MPH Sukaina Hussain, MPH Healthy Lawn Symposium Oct 31, 2014 Two Presentations

More information

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Reliant Medical Group Case Study Organization Profile Reliant Medical Group (formerly Fallon Clinic) was founded in

More information

Please complete the Consent Form and the Respirator Certification Questionnaire.

Please complete the Consent Form and the Respirator Certification Questionnaire. The Occupational Safety and Health Administration (OSHA) Respiratory Protection Standard requires an employee to complete a questionnaire if the employee is required to wear a respirator. You have been

More information

Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care

Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Charley P. Starnes, RRT, RCP Clinical Respiratory Specialist- COPD Education Important Milestones July 2011-

More information

Asthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association.

Asthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association. Asthma Intervention 1. Primary disease education Member will have an increased understanding of asthma and the classification by severity, the risks and the complications. Define asthma Explain how lungs

More information

Male New Patient Package

Male New Patient Package Male New Patient Package The contents of this package are your first step to restore your vitality. Please take time to read this carefully and answer all the questions as completely as possible. Thank

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

The Annual Direct Care of Asthma

The Annual Direct Care of Asthma The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Stonebridge Adult Medicine, P.A. Registration Form (Please Print)

Stonebridge Adult Medicine, P.A. Registration Form (Please Print) Stonebridge Adult Medicine, P.A. Registration Form (Please Print) PATIENT INFORMATION Last Name: First Name: Is this your legal name? Yes No If not what is your legal name: Date of Birth: Sex: male female

More information

Complete coverage. Unbeatable value.

Complete coverage. Unbeatable value. Quest Travel Insurance Complete coverage. Unbeatable value. Quest with confidence, anytime, anywhere! Quest protects you when nothing else can, with: Future stability coverage: Stable now? Not sure you

More information

Respiratory Concerns in Children with Down Syndrome

Respiratory Concerns in Children with Down Syndrome Respiratory Concerns in Children with Down Syndrome Paul E. Moore, M.D. Associate Professor of Pediatrics and Pharmacology Director, Pediatric Allergy, Immunology, and Pulmonary Medicine Vanderbilt University

More information

CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT

CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT HEALTH SERVICES AND PROGRAMS The Plan s Health Promotion and Disease Management Department seeks to improve the health and overall well-being of our

More information

These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:

These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors: Emphysema Pronounced: em-fiss-see-mah by Debra Wood, RN En Español (Spanish Version) Definition Emphysema is a chronic obstructive disease of the lungs. The lungs contain millions of tiny air sacs called

More information

NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL

NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL Appellant: [X] (Worker) Participants entitled to respond to this appeal: [X] (Employer) and The Workers Compensation Board of Nova Scotia (Board) APPEAL

More information